comparemela.com
Home
Live Updates
Xentria's XTMAB-16 Receives Orphan Drug Designation From Eur
Xentria's XTMAB-16 Receives Orphan Drug Designation From Eur
Xentria's XTMAB-16 Receives Orphan Drug Designation From European Medicines Agency as First Patient is Enrolled in Study | Region
CHICAGO--(BUSINESS WIRE)--Nov 15, 2023--
Related Keywords
Chicago ,
Illinois ,
United States ,
Tom Shea ,
Jacqui Wilmot ,
Erin Williams ,
European Medicines Agency ,
Xentria Inc ,
Drug Administration ,
Orphan Drug Designation ,
Orphan Drug ,
Principal Investigator ,
Ogugua Obi ,
Peter Sporn ,
Northwestern Memorial Hospital ,
New Drug Entity ,
Business Wire ,
Region ,